These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 20599486

  • 21. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
    Laufen H, Leitold M.
    Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lowering of sodium deoxycholate-induced nasal ciliotoxicity with cyclodextrins.
    Zhang Y, Jiang XG, Yao J.
    Acta Pharmacol Sin; 2001 Nov; 22(11):1045-50. PubMed ID: 11749799
    [Abstract] [Full Text] [Related]

  • 25. Preparation of prostaglandin E1-hydroxypropyl-beta-cyclodextrin complex and its nasal delivery in rats.
    Gu FG, Cui FD, Gao YL.
    Int J Pharm; 2005 Feb 16; 290(1-2):101-8. PubMed ID: 15664135
    [Abstract] [Full Text] [Related]

  • 26. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S, Diwan PV.
    Pharmazie; 2002 Sep 16; 57(9):632-4. PubMed ID: 12369452
    [Abstract] [Full Text] [Related]

  • 27. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G, Lindberg S, Itoh K, Okada N, Fujita T, Habib F, Artersson P, Attia M, Yamamoto A.
    Int J Pharm; 2005 Apr 11; 293(1-2):127-35. PubMed ID: 15778050
    [Abstract] [Full Text] [Related]

  • 28. [Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies].
    Zhang YJ, Zhang Q, Yang J, Sun MJ, Wang XL, Chen MX, Wang Q, Jiang H.
    Yao Xue Xue Bao; 2007 Nov 11; 42(11):1195-200. PubMed ID: 18300478
    [Abstract] [Full Text] [Related]

  • 29. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ, Balakrishnan P, Park EK, Song KW, Hong SS, Jang TY, Kim KS, Chung SJ, Shim CK, Kim DD.
    J Pharm Sci; 2011 Feb 11; 100(2):681-91. PubMed ID: 20803575
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intranasal toxicity of selected absorption enhancers.
    Haffejee N, Du Plessis J, Müller DG, Schultz C, Kotzé AF, Goosen C.
    Pharmazie; 2001 Nov 11; 56(11):882-8. PubMed ID: 11817176
    [Abstract] [Full Text] [Related]

  • 34. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.
    Zhang T, Li M, Han X, Nie G, Zheng A.
    AAPS PharmSciTech; 2022 May 16; 23(5):143. PubMed ID: 35578146
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Influence of isosorbide dinitrate concentration on its skin permeability from adhesive matrix devices.
    Hatanaka T, Oguchi M, Sugibayashi K, Morimoto Y.
    Chem Pharm Bull (Tokyo); 1991 Jul 16; 39(7):1802-5. PubMed ID: 1777935
    [Abstract] [Full Text] [Related]

  • 40. Nasal drug delivery of sumatriptan succinate.
    Chavanpatil MD, Vavia PR.
    Pharmazie; 2005 May 16; 60(5):347-9. PubMed ID: 15918583
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.